Sara Valpione, MD, PhD, University of Manchester, Manchester, UK, discusses the results of a recently published article in Nature Cancer, where T-cell receptors in plasma cell-free DNA were sequenced and analyzed in a liquid biopsy and were shown to have prognostic value for monitoring response to immunotherapy in patients with melanoma. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).